Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute), 63186 [2016-22059]

Download as PDF 63186 Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices consider all timely and responsive public comments that it receives on or before [30 days from Federal Register date of publication]. For information on the Commission’s privacy policy, including routine uses permitted by the Privacy Act, see https://www.ftc.gov/ftc/ privacy.htm. David C. Shonka, Acting General Counsel. [FR Doc. 2016–22106 Filed 9–13–16; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention asabaliauskas on DSK3SPTVN1PROD with NOTICES Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Times and Dates: 8:00 a.m.–5:00 p.m., EDT, October 11, 2016 (Closed); 8:00 a.m.–5:00 p.m., EDT, October 12, 2016 (Closed). Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: 703–684–5900, Fax: 703– 684–0653. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broad-based research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters for Discussion: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational healthrelated grant applications. VerDate Sep<11>2014 20:55 Sep 13, 2016 Jkt 238001 These portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to section 10(d) Public Law 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Joanne Fairbanks, Designated Federal Officer, NIOSH, CDC, 1095 Willowdale Road, Morgantown, WV 26506, Mailstop L1119, Telephone: (304) 285–6143. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–22059 Filed 9–13–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: Time and Date: 11:00 a.m.–2:00 p.m., EDT, October 4, 2016. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dialin number, 1–866–659–0537, passcode 9933701. Background: The Advisory Board was established under the Energy Employees PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters for Discussion: The agenda for the conference call includes: Final Special Exposure Cohort (SEC) Petition Votes from August ABRWH Meeting for Blockson Chemical Co. (Joliet, Illinois) and Westinghouse Electric Co. (Bloomfield, New Jersey); Bliss and Laughlin Steel SEC Petition (Buffalo, New York), Work Group and Subcommittee Reports; SEC Petitions Update for the November 2016 Advisory Board Meeting; Plans for the November 2016 Advisory Board Meeting; and Advisory Board Correspondence. Contact Person for More Information: Theodore M. Katz, M.P.A., Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop: E–20, Atlanta, Georgia 30333, Telephone (513) E:\FR\FM\14SEN1.SGM 14SEN1

Agencies

[Federal Register Volume 81, Number 178 (Wednesday, September 14, 2016)]
[Notices]
[Page 63186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22059]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Safety and Occupational Health Study Section (SOHSS), National 
Institute for Occupational Safety and Health (NIOSH or Institute)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.
    Times and Dates: 8:00 a.m.-5:00 p.m., EDT, October 11, 2016 
(Closed); 8:00 a.m.-5:00 p.m., EDT, October 12, 2016 (Closed).
    Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 
22314, Telephone: 703-684-5900, Fax: 703-684-0653.
    Purpose: The Safety and Occupational Health Study Section will 
review, discuss, and evaluate grant application(s) received in response 
to the Institute's standard grants review and funding cycles pertaining 
to research issues in occupational safety and health, and allied areas.
    It is the intent of NIOSH to support broad-based research endeavors 
in keeping with the Institute's program goals. This will lead to 
improved understanding and appreciation for the magnitude of the 
aggregate health burden associated with occupational injuries and 
illnesses, as well as to support more focused research projects, which 
will lead to improvements in the delivery of occupational safety and 
health services, and the prevention of work-related injury and illness. 
It is anticipated that research funded will promote these program 
goals.
    Matters for Discussion: The meeting will convene to address matters 
related to the conduct of Study Section business and for the study 
section to consider safety and occupational health-related grant 
applications.
    These portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, Centers for Disease Control and 
Prevention, pursuant to section 10(d) Public Law 92-463.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Joanne Fairbanks, Designated 
Federal Officer, NIOSH, CDC, 1095 Willowdale Road, Morgantown, WV 
26506, Mailstop L1119, Telephone: (304) 285-6143.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-22059 Filed 9-13-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.